Targeting leptin/CCL3-CCL4 axes in NAFLD/MAFLD: A novel role for BPF in counteracting thalamic inflammation and white matter degeneration

• Egile Nagusiak: Antonio Cardamone (Egilea), Anna Rita Coppoletta (Egilea), Roberta Macrì (Egilea), Saverio Nucera (Egilea), Stefano Ruga (Egilea), Federica Scarano (Egilea), Rocco Mollace (Egilea), Annachiara Mollace (Egilea), Samantha Maurotti (Egilea), Edoardo Micotti (Egilea), Cristina Carresi (Egilea), Vincenzo Musolino (Egilea), Micaela Gliozzi (Egilea), Vincenzo Mollace (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2024-11-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Non-alcoholic fatty liver disease (NAFLD), redefined as Metabolic Associated Fatty Liver Disease (MAFLD), is characterized by an extensive multi-organ involvement. MAFLD-induced systemic inflammatory status and peripheral metabolic alteration lead to an impairment of cerebral function. Herein, we in...